Ceribell
CBLL18.5201.15% ( +0.210 )
Ceribell (CBLL)
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifical...
- Open
- 18.310
- High
- 18.660
- Low
- 18.010
- Prev. Close
- 18.310
- Volume
- 326.81K
- Turnover
- 6.01M
- Avg Price
- 18.375
- Bid/Ask Ratio
- --
- Amplitude
- 3.55%
- 52wk High
- 24.330
- Volume Ratio
- 0.60
- Turnover Ratio
- 1.25%
Ceribell Analyst Rating
View MoreForecast & Rating
Aug 3, 2026Price forecast
$26.8645.02%
Forecast & RatingStrong buy
8analysts
- Strong buy87.50%
- Buy12.50%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 1 day ago, 06:03 AM
Ceribell wins CMS NTAP for delirium monitor, worth up to $2,171 per Medicare case
- Unusual Whales · 1 day ago, 06:03 AM
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
- Market Beat · 1 day ago, 02:56 AM
CeriBell (CBLL) Expected to Announce Quarterly Earnings on Monday
- PUBT · Jul 30 at 06:39 PM
Ceribell files Form 3 initial beneficial ownership statement for director Sharon O’Keefe
- PUBT · Jul 29 at 06:04 AM
Ceribell names Thomas West, Sharon O’Keefe to board of directors
- PUBT · Jul 28 at 03:13 PM
Ceribell CFO to join Canaccord Genuity Growth Conference fireside chat
